A Phase 3, Multicenter, Double blind, Randomized, Placebo controlled, Parallel group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/CALHN/106 (ERM Project ID 43805)
NMA SSA Reference Number: SSA/43805/MonH-2019-166426(v1)
Monash Health Ref: RES-19-0000-148X
StatusActive
Effective start/end date8/03/197/03/24